Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
5.20
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Cordyceps Sunshine Biotech Holdings PE Ratio
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio Data
| Date | Value |
|---|---|
| January 17, 2025 | 29666.67 |
| January 16, 2025 | 29666.67 |
| January 15, 2025 | 28600.00 |
| January 14, 2025 | 27733.33 |
| January 13, 2025 | 27733.33 |
| January 10, 2025 | 27733.33 |
| January 08, 2025 | 27500.00 |
| January 07, 2025 | 27500.00 |
| January 06, 2025 | 27500.00 |
| January 03, 2025 | 27500.00 |
| January 02, 2025 | 27500.00 |
| December 31, 2024 | 27500.00 |
| December 30, 2024 | 27500.00 |
| December 27, 2024 | 27500.00 |
| December 26, 2024 | 27500.00 |
| December 24, 2024 | 27500.00 |
| December 23, 2024 | 27500.00 |
| December 20, 2024 | 27266.67 |
| December 19, 2024 | 27266.67 |
| December 18, 2024 | 27266.67 |
| December 17, 2024 | 27266.67 |
| December 16, 2024 | 27266.67 |
| December 13, 2024 | 27266.67 |
| December 12, 2024 | 25833.33 |
| December 11, 2024 | 25833.33 |
| Date | Value |
|---|---|
| December 10, 2024 | 25833.33 |
| December 09, 2024 | 23000.00 |
| December 06, 2024 | 23000.00 |
| December 05, 2024 | 23000.00 |
| December 04, 2024 | 23000.00 |
| December 03, 2024 | 23000.00 |
| December 02, 2024 | 23000.00 |
| November 29, 2024 | 23000.00 |
| November 27, 2024 | 23000.00 |
| November 26, 2024 | 20000.00 |
| November 25, 2024 | 20000.00 |
| November 22, 2024 | 20000.00 |
| November 21, 2024 | 18300.00 |
| November 20, 2024 | 18300.00 |
| November 19, 2024 | 16833.33 |
| November 18, 2024 | 16833.33 |
| November 15, 2024 | 16666.67 |
| November 14, 2024 | 15833.33 |
| November 13, 2024 | 12266.67 |
| November 12, 2024 | 10000.00 |
| November 11, 2024 | 10000.00 |
| November 08, 2024 | 10000.00 |
| November 07, 2024 | 10000.00 |
| November 06, 2024 | 10000.00 |
| November 05, 2024 | 10000.00 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
PE Ratio Related Metrics
| Price | 5.20 |
| Market Cap | 577.82M |